Developer docs
API playgroundTry for free, no card

Search company profiles

Elevate Clinical Research

Full company profile

uuid002vlci

Namestring
Elevate Clinical Research
Legal namestring
Elevate Clinical Research, Inc.
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Elevate Clinical Research, Inc. is a private, Delaware-incorporated site management organization (SMO) founded in 2024 and headquartered in Fort Worth, Texas. The company operates a growing network of clinical research sites across the United States — including owned locations in Houston, McAllen, Lake Charles, Gurnee, Rockville, and Wichita; joint-venture sites Elevate Synapsis (Atascocita, TX, with Synapsis Bio) and Elevate Up (Waxahachie, TX, with Dallas Neurology Care Clinic); and a decentralized division that reaches patients in 48 states through Dr. Kinjal Desai. Elevate runs trials from Phase 1b through Phase 4 across therapeutic areas including neurology, psychiatry, gastroenterology, cardiovascular/metabolic/renal, endocrinology, pulmonology, ophthalmology, women's health, family medicine, and infectious disease/vaccines.

The company's core technology stack is built around its membership in CRIO's Partners Program (joined July 2024), through which Elevate provides same-day EDC data entry (with most site visits entered overnight and 60-90% of queries resolved same-day), eRegulatory and eISF document management, and multi-channel patient recruitment with rigorous pre-screening to lower screen-fail rates. There is no proprietary AI or ML layer disclosed; all automation and workflow tooling is layered on top of the CRIO platform. Elevate holds HIPAA-compliant operational policies and runs specialized facilities, notably the 28-room Synapsis Phase 1b-capable site.

Elevate's revenue model has two distinct streams: (1) Clinical Trial Services, where the company is compensated on a transaction-fee basis for conducting trials and enrolling patients on behalf of pharmaceutical sponsors and CROs; and (2) Site Partner Services, a managed-services offering (business development, finance, regulatory, data entry, and recruitment) sold to existing independent research sites that join the Elevate network in exchange for fees. The company is sales-led with channel-partner distribution through its site partner network, and reaches patients via content marketing, social media, industry events, and direct outreach. As of the available data, the company has filed an SEC Form D for a minimum $1M equity raise (June 2025) and operates with a small central team (1-10 employees listed) while scaling across multiple geographies.

Short descriptiontext

Elevate Clinical Research is a private site management organization operating a multi-state US network of clinical research sites and decentralized trials, conducting Phase 1b-4 studies across multiple therapeutic areas for pharmaceutical sponsors, CROs, and partner sites.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial management, site management organization, patient recruitment services, clinical research services, clinical trial conduct
Industry2 codes
PRIMARYHLAGACAA
Site Network Operators & SMOs
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Health Services8000
Product category
Clinical Research Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Trial Services
TypeTransaction Fee
Description

Revenue generated from conducting clinical trials for pharmaceutical sponsors and CROs. The company operates clinical research sites and provides site management services, receiving compensation for each trial conducted and patient enrolled.

elevateclinical.com
2Site Partner Services
TypeManaged Services
Description

Business development, operational support, financial management, regulatory compliance, data entry, and patient recruitment services provided to partner research sites in exchange for fees.

elevateclinical.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Elevate Clinical Research is a site management organization that operates a network of clinical research sites across the United States, conducting Phase 1 through Phase 4 trials in multiple therapeutic areas for pharmaceutical sponsors and CROs. The company also provides site partner services—business development, operational support, regulatory management, patient recruitment, and data entry services—to existing clinical research sites that join its network. Its portfolio includes owned sites, joint venture sites with specialist physicians, and decentralized trial operations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 125% of enrollment target achieved on migraine trial using partner technology
Product overview1 text field

Elevate Clinical Research is a full-service clinical research site management organization that operates a network of clinical trial sites across the United States. The company provides core site management services including patient recruitment, data entry management, regulatory management, and operational support for sponsors and CROs. Their portfolio includes both owned research sites (Houston, McAllen, Lake Charles, Gurnee, Rockville, Wichita) and joint venture sites (Elevate Synapsis in Atascocita, TX and Elevate Up in Waxahachie, TX), as well as a decentralized trials division operating nationwide. The company also offers site partner services including business development, finance support, and recruitment services for clinical research sites joining their network.

Product and service6 records
1Clinical Trial Site Management Services
CategoryCore site management services
Description

Full-service clinical trial conduct for pharmaceutical sponsors and CROs across multiple therapeutic areas, including patient recruitment, site management, regulatory compliance, data entry, and operational support delivered through Elevate's network of research sites.

2Elevate Decentralized
CategoryDecentralized trial services
Description

Decentralized clinical research service that operates without a fixed physical location and remotely connects with patients across 48 states to conduct trials and reach broad, diverse populations.

3Site Partner Services
CategorySite partner network services
Description

Business development, budget negotiation, operational support, financial management, regulatory management, data entry management, and patient recruitment services provided to existing clinical research sites that join Elevate's site network.

4Elevate Synapsis - Atascocita, TX
CategoryJoint venture research site (CNS / Phase 1-4)
Description

Joint venture with Synapsis Bio featuring 28 rooms for Phase 1b through Phase 4 clinical trials with both inpatient and outpatient capabilities, led by Dr. Matthew Brams, a board-certified psychiatrist with over 26 years of experience and over 300 clinical trials conducted.

5Elevate Up - Waxahachie, TX
CategoryJoint venture research site (Neurology)
Description

Joint venture with Dallas Neurology Care Clinic in Waxahachie, Texas, focused on neurology clinical trials and led by Dr. Khalid, a board-certified neurologist specializing in diagnosing and treating complex neurological disorders.

6Owned Research Site Network
CategoryOwned research site network
Description

Company-owned clinical research sites in Houston (TX), McAllen (TX), Lake Charles (LA), Gurnee (IL), Rockville (MD), and Wichita (KS), providing access to diverse patient populations across family medicine, endocrinology, cardiovascular/metabolic/renal, gastroenterology, neurology, pulmonology, women's health, and other therapeutic areas.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-07-15
Description

Elevate Clinical Research joined CRIO's Partners Program, providing data entry and site operations services to CRIO-powered clinical research sites. Elevate's global staff enters source data into the EDC daily with most site visits entered overnight, resolving 60-90% of queries same-day. They also provide weekly metrics, source QC review, and coordinator training.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Mid-to-large CRO with strong sponsor relationships and centralized site management functions, frequently competing for the same Phase 1–4 studies Elevate targets.

TypeBroad incumbent
Description

Provider of clinical trial site activation, IRB, and technology services used by sponsors, CROs, and sites. Adjacent infrastructure layer that Elevate's regulatory and site activation services partially overlap with.

3CRIO
TypeOthers
Description

eRegulatory and EDC platform provider for clinical research sites. Directly comparable as the technology backbone Elevate has integrated, and serves the same site-operator customer base.

TypeBroad incumbent
Description

Largest global CRO/SMO with deep sponsor relationships, dedicated site network, and significant bargaining power on study awards. Represents the dominant competitor Elevate must differentiate against.

TypeDirect peer
Description

Multi-specialty clinical research site network operating across multiple US states with therapeutic breadth similar to Elevate. Competes for the same sponsor study awards.

TypeDirect peer
Description

SMO that combines owned sites, partner physician practices, and decentralized trial operations to serve sponsors and CROs. Closely mirrors Elevate's hybrid owned + JV + decentralized model.

TypeDirect peer
Description

Integrated clinical research organization partnering with healthcare practices and academic systems to embed trials, with an analogous focus on operationalizing existing clinical sites for sponsor trials.

TypeDirect peer
Description

Multi-site SMO operating owned and affiliated clinical trial sites across the US with similar therapeutic breadth and sponsor-facing services. Most directly comparable business model to Elevate's owned-and-partner site network.

TypeBroad incumbent
Description

Global CRO (formed via PRA Health Sciences combination) with site and patient access capabilities. Sets the bar for sponsor expectations around scale and operational metrics.

TypeEmerging player
Description

Patient logistics and concierge services for clinical trial participants, comparable to Elevate's emphasis on recruitment and patient-retention services for sponsors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Elevate Clinical Research

Clinical Research Serviceselevateclinical.com

Elevate Clinical Research is a private site management organization operating a multi-state US network of clinical research sites and decentralized trials, conducting Phase 1b-4 studies across multiple therapeutic areas for pharmaceutical sponsors, CROs, and partner sites.

What Elevate Clinical Research does

Elevate Clinical Research, Inc. is a private, Delaware-incorporated site management organization (SMO) founded in 2024 and headquartered in Fort Worth, Texas. The company operates a growing network of clinical research sites across the United States — including owned locations in Houston, McAllen, Lake Charles, Gurnee, Rockville, and Wichita; joint-venture sites Elevate Synapsis (Atascocita, TX, with Synapsis Bio) and Elevate Up (Waxahachie, TX, with Dallas Neurology Care Clinic); and a decentralized division that reaches patients in 48 states through Dr. Kinjal Desai. Elevate runs trials from Phase 1b through Phase 4 across therapeutic areas including neurology, psychiatry, gastroenterology, cardiovascular/metabolic/renal, endocrinology, pulmonology, ophthalmology, women's health, family medicine, and infectious disease/vaccines.

The company's core technology stack is built around its membership in CRIO's Partners Program (joined July 2024), through which Elevate provides same-day EDC data entry (with most site visits entered overnight and 60-90% of queries resolved same-day), eRegulatory and eISF document management, and multi-channel patient recruitment with rigorous pre-screening to lower screen-fail rates. There is no proprietary AI or ML layer disclosed; all automation and workflow tooling is layered on top of the CRIO platform. Elevate holds HIPAA-compliant operational policies and runs specialized facilities, notably the 28-room Synapsis Phase 1b-capable site.

Elevate's revenue model has two distinct streams: (1) Clinical Trial Services, where the company is compensated on a transaction-fee basis for conducting trials and enrolling patients on behalf of pharmaceutical sponsors and CROs; and (2) Site Partner Services, a managed-services offering (business development, finance, regulatory, data entry, and recruitment) sold to existing independent research sites that join the Elevate network in exchange for fees. The company is sales-led with channel-partner distribution through its site partner network, and reaches patients via content marketing, social media, industry events, and direct outreach. As of the available data, the company has filed an SEC Form D for a minimum $1M equity raise (June 2025) and operates with a small central team (1-10 employees listed) while scaling across multiple geographies.

Elevate Clinical Research firmographics

Firmographics
Name
Elevate Clinical Research
Legal name
Elevate Clinical Research, Inc.
Website
https://elevateclinical.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Elevate Clinical Research is a private site management organization operating a multi-state US network of clinical research sites and decentralized trials, conducting Phase 1b-4 studies across multiple therapeutic areas for pharmaceutical sponsors, CROs, and partner sites.
Ownership category
akta.pro rank

Elevate Clinical Research industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGACAA
Site Network Operators & SMOs
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)

Keywords

  • Clinical trial management
  • Site management organization
  • Patient recruitment services
  • Clinical research services
  • Clinical trial conduct

Where Elevate Clinical Research is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices10 records

Markets served

Elevate Clinical Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Trial Services: Revenue generated from conducting clinical trials for pharmaceutical sponsors and CROs. The company operates clinical research sites and provides site management services, receiving compensation for each trial conducted and patient enrolled.
  2. Site Partner Services: Business development, operational support, financial management, regulatory compliance, data entry, and patient recruitment services provided to partner research sites in exchange for fees.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Elevate Clinical Research product offering

Product offering

Core offering

Elevate Clinical Research is a site management organization that operates a network of clinical research sites across the United States, conducting Phase 1 through Phase 4 trials in multiple therapeutic areas for pharmaceutical sponsors and CROs. The company also provides site partner services—business development, operational support, regulatory management, patient recruitment, and data entry services—to existing clinical research sites that join its network. Its portfolio includes owned sites, joint venture sites with specialist physicians, and decentralized trial operations.

Product overview

Elevate Clinical Research is a full-service clinical research site management organization that operates a network of clinical trial sites across the United States. The company provides core site management services including patient recruitment, data entry management, regulatory management, and operational support for sponsors and CROs. Their portfolio includes both owned research sites (Houston, McAllen, Lake Charles, Gurnee, Rockville, Wichita) and joint venture sites (Elevate Synapsis in Atascocita, TX and Elevate Up in Waxahachie, TX), as well as a decentralized trials division operating nationwide. The company also offers site partner services including business development, finance support, and recruitment services for clinical research sites joining their network.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Trial Site Management Services Full-service clinical trial conduct for pharmaceutical sponsors and CROs across multiple therapeutic areas, including patient recruitment, site management, regulatory compliance, data entry, and operational support delivered through Elevate's network of research sites.
  • Elevate Decentralized Decentralized clinical research service that operates without a fixed physical location and remotely connects with patients across 48 states to conduct trials and reach broad, diverse populations.
  • Site Partner Services Business development, budget negotiation, operational support, financial management, regulatory management, data entry management, and patient recruitment services provided to existing clinical research sites that join Elevate's site network.
  • Elevate Synapsis - Atascocita, TX Joint venture with Synapsis Bio featuring 28 rooms for Phase 1b through Phase 4 clinical trials with both inpatient and outpatient capabilities, led by Dr. Matthew Brams, a board-certified psychiatrist with over 26 years of experience and over 300 clinical trials conducted.
  • Elevate Up - Waxahachie, TX Joint venture with Dallas Neurology Care Clinic in Waxahachie, Texas, focused on neurology clinical trials and led by Dr. Khalid, a board-certified neurologist specializing in diagnosing and treating complex neurological disorders.
  • Owned Research Site Network Company-owned clinical research sites in Houston (TX), McAllen (TX), Lake Charles (LA), Gurnee (IL), Rockville (MD), and Wichita (KS), providing access to diverse patient populations across family medicine, endocrinology, cardiovascular/metabolic/renal, gastroenterology, neurology, pulmonology, women's health, and other therapeutic areas.

Quantifiable outcome

  • 125% of enrollment target achieved on migraine trial using partner technology

Companies that use Elevate Clinical Research

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Elevate Clinical Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Elevate Clinical Research partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CRIOcoreTechnology or Integration · 15 July 2024Elevate Clinical Research joined CRIO's Partners Program, providing data entry and site operations services to CRIO-powered clinical research sites. Elevate's global staff enters source data into the EDC daily with most site visits entered overnight, resolving 60-90% of queries same-day. They also provide weekly metrics, source QC review, and coordinator training.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Elevate Clinical Research competitors and assessment

Company assessment

Broad incumbents

  • Medpace: Mid-to-large CRO with strong sponsor relationships and centralized site management functions, frequently competing for the same Phase 1–4 studies Elevate targets.
  • WCG Clinical: Provider of clinical trial site activation, IRB, and technology services used by sponsors, CROs, and sites. Adjacent infrastructure layer that Elevate's regulatory and site activation services partially overlap with.
  • IQVIA: Largest global CRO/SMO with deep sponsor relationships, dedicated site network, and significant bargaining power on study awards. Represents the dominant competitor Elevate must differentiate against.
  • ICON plc: Global CRO (formed via PRA Health Sciences combination) with site and patient access capabilities. Sets the bar for sponsor expectations around scale and operational metrics.

Others

  • CRIO: eRegulatory and EDC platform provider for clinical research sites. Directly comparable as the technology backbone Elevate has integrated, and serves the same site-operator customer base.

Direct peers

  • Flourish Research: Multi-specialty clinical research site network operating across multiple US states with therapeutic breadth similar to Elevate. Competes for the same sponsor study awards.
  • Elligo Health Research: SMO that combines owned sites, partner physician practices, and decentralized trial operations to serve sponsors and CROs. Closely mirrors Elevate's hybrid owned + JV + decentralized model.
  • Javara: Integrated clinical research organization partnering with healthcare practices and academic systems to embed trials, with an analogous focus on operationalizing existing clinical sites for sponsor trials.
  • Velocity Clinical Research: Multi-site SMO operating owned and affiliated clinical trial sites across the US with similar therapeutic breadth and sponsor-facing services. Most directly comparable business model to Elevate's owned-and-partner site network.

Emerging players

  • Clincierge: Patient logistics and concierge services for clinical trial participants, comparable to Elevate's emphasis on recruitment and patient-retention services for sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Elevate Clinical Research social profiles

Digital presence

Elevate Clinical Research compliance and trust

Trust signal

Compliance1 record

Elevate Clinical Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Elevate Clinical Research leadership team

Management profile

Number of profiles

Profiles2 records

Elevate Clinical Research subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Elevate Clinical Research funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Elevate Clinical Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elevate Clinical Research

What does Elevate Clinical Research do?

Elevate Clinical Research is a site management organization that operates a network of clinical research sites across the United States, conducting Phase 1 through Phase 4 trials in multiple therapeutic areas for pharmaceutical sponsors and CROs. The company also provides site partner services—business development, operational support, regulatory management, patient recruitment, and data entry services—to existing clinical research sites that join its network. Its portfolio includes owned sites, joint venture sites with specialist physicians, and decentralized trial operations.

Is Elevate Clinical Research a public or private company?

Elevate Clinical Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Elevate Clinical Research founded?

Elevate Clinical Research was founded in 2024. It employs 11 to 50 people.

Where is Elevate Clinical Research based?

Elevate Clinical Research is headquartered in Houston, United States, in the North America region.

How does Elevate Clinical Research make money?

Two revenue lines are on record. Clinical Trial Services are the primary driver. The others are site Partner Services.

Who are Elevate Clinical Research's main competitors?

Broad incumbents on record are Medpace, WCG Clinical, IQVIA and ICON plc. CRIO is listed as an others. Direct peers are Flourish Research, Elligo Health Research, Javara and Velocity Clinical Research. Clincierge is listed as an emerging player.

Does Elevate Clinical Research have an API?

No public API is recorded for Elevate Clinical Research.

What industry is Elevate Clinical Research in?

Elevate Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAA, Site Network Operators & SMOs, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNeurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders MarketNeurophet signed a supply agreement with Elevate Clinic in the U.S. to provide Neurophet AQUA and AQUA AD Plus, AI-powered brain imaging analysis software. The clinic, specializing in neurological disorders, will use the software for brain atrophy and microhemorrhage detection. Neurophet plans to expand clinical adoption across U.S. hospitals using Elevate Clinic as a reference site.SecSEC FORM DThe SEC filed a Form D notice of an exempt securities offering by Elevate Clinical Research, Inc., a Delaware corporation, which plans to offer equity securities with a minimum investment of $5,000, targeting investors in the United States. The offering is scheduled to begin in June 2025, with no specified end date, and has already sold $1 million.UpstartsmediaThe Startup Speeding Up Clinical Trials With Voice AIDelfa, a London-based startup, has developed voice AI software to automate patient recruitment for clinical trials, addressing a process that can consume up to a third of trial costs. The company has raised $3.8 million in seed funding led by Air Street Capital, with Saras Capital participating, and is currently powering more than 50 trials while in talks to pilot with two of the top 20 global pharma companies. Early customer Elevate Medical Research achieved 125% of its target on a migraine trial using Delfa's technology, saving the equivalent of thousands of recruiter hours.